PEDIATRICS Vol. 95 No. 4 April 1995, pp. 584-590
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Durand, M.
Right arrow Articles by McEvoy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Durand, M.
Right arrow Articles by McEvoy, C.

Effects of Early Dexamethasone Therapy on Pulmonary Mechanics and Chronic Lung Disease in Very Low Birth Weight Infants: A Randomized, Controlled Trial

Manuel Durand MD1, Smeeta Sardesai MD2, and Cindy McEvoy MD2

1 Division of Neonatal-Perinatal Medicine, Los Angeles County + University of Southern California Medical Center
2 Department of Pediatrics, University of Southern California School of Medicine, Los Angeles

Objective. To determine the changes in pulmonary mechanics before and during early dexamethasone therapy, and to evaluate the effect of dexamethasone on the duration of mechanical ventilation in very low birth weight (VLBW) ventilator-dependent infants at risk for chronic lung disease (CLD).

Methods. A prospective randomized trial was conducted. Forty-three patients (birth weight 600 to 1500 g, gestational age 24 to 32 weeks) who failed to be weaned from the respirator at 7 to 14 days of age were enrolled; 23 infants received a 7-day course of dexamethasone (0.5 mg/kg/day intravenously for 3 days, 0.25 mg/kg/day for 3 days, and 0.1 mg/kg/day for 1 day), and 20 patients were in the control group. At similar mean airway pressure (MAP) and fractional inspired oxygen concentration (FiO2), respiratory system mechanics were measured before and on days 2, 5, and 7 of the study. Airway pressure, flow and tidal volume (VT) were recorded and only mechanical breaths were analyzed. Respiratory compliance (Crs) and respiratory resistance (Rrs) were calculated by two factor least mean square analysis.

Results. Eighty-three percent of infants in the dexamethasone group and 90% in the control group received surfactant in the first 24 hours of life. There was a significant increase in Crs and VT in the dexamethasone group as compared with the control group (P < .001). No major changes in Rrs were observed. Dexamethasone therapy significantly decreased FiO2 and MAP P < .001) and facilitated successful weaning from mechanical ventilation. In addition to a shorter duration of mechanical ventilation (P < .01), the occurrence of CLD (FiO2 > 0.21 at 36 weeks of corrected gestational age, chest radiograph changes) was significantly decreased in the dexamethasone group (P < .01). Except for a transient increase in blood pressure and serum glucose, there were no significant differences in infection rates, intraventricular hemorrhage, or retinopathy of prematurity. Thirteen patients in the control group received dexamethasone at a later age.

Conclusions. Our findings indicate that: 1) early dexamethasone therapy in VLBW infants markedly improves respiratory compliance and tidal volume, reduces FiO2 and MAP requirements, and facilitates extubation in these infants; 2) early dexamethasone therapy reduces the duration of mechanical ventilation and decreases CLD (at 28 days and 36 weeks) in a population of VLBW infants largely treated with surfactant.

Submitted on October 18, 1994
Accepted on January 25, 1995




This article has been cited by other articles:


Home page
 PediatricsHome page
W. Onland, A. P. De Jaegere, M. Offringa, and A. H. van Kaam
Effects of Higher Versus Lower Dexamethasone Doses on Pulmonary and Neurodevelopmental Sequelae in Preterm Infants at Risk for Chronic Lung Disease: A Meta-analysis
Pediatrics, July 1, 2008; 122(1): 92 - 101.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. McEvoy, S. Bowling, K. Williamson, D. Lozano, L. Tolaymat, L. Izquierdo, J. Maher, and A. Helfgott
The Effect of a Single Remote Course Versus Weekly Courses of Antenatal Corticosteroids on Functional Residual Capacity in Preterm Infants: A Randomized Trial
Pediatrics, August 1, 2002; 110(2): 280 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. C. Rathman, B. Lewis, and R. J. McMahon
Acute glucocorticoid treatment increases urinary biotin excretion and serum biotin
Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E643 - E649.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
D L Armstrong, J Penrice, F H Bloomfield, D B Knight, J A Dezoete, and J E Harding
Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2002; 86(2): F102 - F107.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
B. A. Banks
Postnatal Dexamethasone for Bronchopulmonary Dysplasia: A Systematic Review and Meta-analysis of 20 Years of Clinical Trials
NeoReviews, February 1, 2002; 3(2): e24 - 34.
[Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. L. RAMSAY, F. J. DeMAYO, S. E. HEGEMIER, M. E. WEARDEN, C. V. SMITH, and S. E. WELTY
Clara Cell Secretory Protein Oxidation and Expression in Premature Infants Who Develop Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 155 - 161.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. P. Shenai, B. G. Mellen, and F. Chytil
Vitamin A Status and Postnatal Dexamethasone Treatment in Bronchopulmonary Dysplasia
Pediatrics, September 1, 2000; 106(3): 547 - 553.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
S. K Sinha and S. M Donn
Weaning from assisted ventilation: art or science?
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2000; 83(1): 64F - 70.
[Full Text]

Home page
 PediatricsHome page
R. A. Sinkin, H. S. Dweck, M. J. Horgan, K. J. Gallaher, C. Cox, W. M. Maniscalco, P. R. Chess, C. T. D'Angio, R. Guillet, J. W. Kendig, et al.
Early Dexamethasone---Attempting To Prevent Chronic Lung Disease
Pediatrics, March 1, 2000; 105(3): 542 - 548.
[Abstract] [Full Text]

Home page
 PediatricsHome page
T. M. O'Shea, J. M. Kothadia, K. L. Klinepeter, D. J. Goldstein, B. G. Jackson, and R. G. Weaver
Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants: Outcome of Study Participants at 1-Year Adjusted Age
Pediatrics, July 1, 1999; 104(1): 15 - 21.
[Abstract] [Full Text]

Home page
 NEJMHome page
C. H. Cole, T. Colton, B. L. Shah, S. Abbasi, B. L. MacKinnon, S. Demissie, and I. D. Frantz
Early Inhaled Glucocorticoid Therapy to Prevent Bronchopulmonary Dysplasia
N. Engl. J. Med., April 1, 1999; 340(13): 1005 - 1010.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Kothadia, T. M. O'Shea, D. Roberts, S. T. Auringer, R. G. Weaver, and I.{s. a. R. G. Dillard
Randomized Placebo-controlled Trial of a 42-Day Tapering Course of Dexamethasone to Reduce the Duration of Ventilator Dependency in Very Low Birth Weight Infants
Pediatrics, January 1, 1999; 104(1): 22 - 27.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
F H BLOOMFIELD, D B KNIGHT, and J E HARDING
Which course of dexamethasone?
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1999; 80(1): 78F - 78.
[Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
A. Pellicer, F. Gayá, T. A Stiris, J. Quero, and F. Cabañas
Cerebral haemodynamics in preterm infants after exposure to dexamethasone
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1998; 79(2): 123F - 128.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
T. Bhuta and A. Ohlsson
Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1998; 79(1): 26F - 33.
[Abstract] [Full Text]

Home page
 PediatricsHome page
T. F. Yeh, Y. J. Lin, C. C. Huang, Y. J. Chen, C. H. Lin, H. C. Lin, W. S. Hsieh, and Y. J. Lien
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Pediatrics, May 1, 1998; 101 (5): e7 - e7.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
C. Kuschel, N. Evans, and A. Lam
Prediction of individual response to postnatal dexamethasone in ventilator dependent preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 1998; 78(3): 199F - 203.
[Abstract] [Full Text]

Home page
 NEJMHome page
L.-A. Papile, J. E. Tyson, B. J. Stoll, L. L. Wright, E. F. Donovan, C. R. Bauer, H. Krause-Steinrauf, J. Verter, S. B. Korones, J. A. Lemons, et al.
A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants
N. Engl. J. Med., April 16, 1998; 338(16): 1112 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. M. O'Shea, K. L. Klinepeter, D. J. Goldstein, B. W. Jackson, and R. G. Dillard
Survival and Developmental Disability in Infants With Birth Weights of 501 to 800 Grams, Born Between 1979 and 1994
Pediatrics, December 1, 1997; 100(6): 982 - 986.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. F. Yeh, Y. J. Lin, W. S. Hsieh, H. C. Lin, C. H. Lin, J. Y. Chen, H. A. Kao, and C. H. Chien
Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease in Preterm Infants With Respiratory Distress Syndrome: A Multicenter Clinical Trial
Pediatrics, October 1, 1997; 100(4): e3 - e3.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. Kugelman, M. Durand, and M. Garg
Pulmonary Effect of Inhaled Furosemide in Ventilated Infants With Severe Bronchopulmonary Dysplasia
Pediatrics, January 1, 1997; 99(1): 71 - 75.
[Abstract] [Full Text] [PDF]